Gilead Sciences Inc (NASDAQ:GILD)

Friday’s trading has closed, but GILD is being traded in the after-hours session. After-Hours quote »
89.84
Data as of 4:00pm ET
 -0.70 / -0.77%
Today’s Change
55.96
Today|||52-Week Range
92.97
+19.63%
Year-to-Date
I'm Less Skeptical After These Results
10:25am / TheStreet.com
3 Stocks to Get on Your Watchlist
Jul 23 / MotleyFool.com
Why Gilead Stock's Newest Drug Approval Isn't a Gamechanger
8:31am / MotleyFool.com
Two Giants Blindsided by Major Trends
Jul 23 / TheStreet.com
Why Gilead Sciences, inc. Stock Was Flat Today
Jul 24 / MotleyFool.com
Statement from FDA Confirms Approval of Gilead's Zydelig
Jul 23 / Benzinga
Biotech Stocks With Unique Diagnostic and Therapeutic Technologies
Jul 24 / Investing Channel
Earnings Scheduled For July 23, 2014
Jul 23 / Benzinga
3 Crucial Quotes From Gilead Sciences Stock
Jul 24 / MotleyFool.com
3 Things You Need to Watch on Gilead Sciences Inc. Earnings Call
Jul 22 / MotleyFool.com
Alexion Pharmaceuticals Q2 Earnings In Line; Revises View - Analyst Blog
Jul 24 / Zacks.com
3 Quotes From Johnson & Johnson's Conference Call You Need to Read
Jul 22 / MotleyFool.com
What Gilead Stock's Latest Blockbuster Approval Means for Investors
Jul 24 / MotleyFool.com
Gilead Expected to Post Sky-High Hep C Sales in June Quarter
Jul 22 / TheStreet.com
Healthcare Spending to Trend Up in 2015: 3 Healthcare Fund Picks - Best of Funds
Jul 24 / Zacks.com
Will Gilead (GILD) Earnings Disappoint in Q2 as Costs Rise? - Analyst Blog
Jul 22 / Zacks.com
3 Game-Changing Stories That Shook Investors: Inovio Pharmaceuticals, Gilead Sciences...
Jul 24 / MotleyFool.com
Do This Drug's Sales Make J&J a Hepatitis C Powerhouse?
Jul 22 / MotleyFool.com
3 Stocks Improving Performance Of The Health Care Sector
Jul 24 / TheStreet.com
Gilead Earnings: Can Sovaldi Reach $3 Billion?
Jul 21 / MotleyFool.com
Jim Cramer's Mad Dash: Gilead Sciences Still Has Upside
Jul 24 / TheStreet.com
Why I'm Shorting Gilead: Sentiment Is Too Positive Ahead of Earnings
Jul 21 / TheStreet.com
Stock Market News for July 24, 2014 - Market News
Jul 24 / Zacks.com
Yellen Hates Biotech Stocks! Should You?
Jul 21 / MotleyFool.com
Gilead Crushes Q2 Earnings Estimates as Sovaldi Sales Soar - Analyst Blog
Jul 24 / Zacks.com
Gilead (GILD) Reaches New Lifetime High Today
Jul 21 / TheStreet.com
Frontrunning: July 24
Jul 24 / Investing Channel
How Will Gilead Sciences (GILD) Stock Be Affected By Solvadi Hepatitis C Finding?
Jul 21 / TheStreet.com
Today's Momo Momentum Stock To Watch: Gilead (GILD)
Jul 24 / TheStreet.com
Investors Focus On Earnings Rather Than Geopolitical Tensions
Jul 18 / Benzinga
Gilead Beats Q2 Views On Revenue Growth Lead By Sovaldi Drug
Jul 24 / Benzinga
Gilead Sciences Stock's Huge Hidden Opportunity
Jul 18 / MotleyFool.com
Jim Cramer's Top Stock Picks: PEP CELG GILD REGN BIIB CMG
Jul 24 / TheStreet.com
Healthcare ETFs In Focus On Johnson & Johnson Earnings
Jul 18 / Investing Channel
Gilead Stock's Great Expectations and Giant Opportunity
Jul 23 / MotleyFool.com
Removing SanDisk from Top Five
Jul 18 / TheStreet.com
Gilead Sciences Crushes Second-Quarter Earnings
Jul 23 / MotleyFool.com
Do Johnson & Johnson's Results Suggest a Pop or Drop for Gilead Sciences?
Jul 17 / MotleyFool.com
Markets Mostly Higher As Earnings Season Continues To Impress
Jul 23 / Benzinga
Gilead Stock Earnings: What to Watch
Jul 16 / MotleyFool.com
Is Gilead About to Crush Pharmacyclics Stock?
Jul 23 / MotleyFool.com
Keep Calm and Carry On, J&J
Jul 16 / MotleyFool.com
How Will Gilead Sciences (GILD) Stock Be Affected By Its Second Quarter Earnings Resu...
Jul 23 / TheStreet.com
Stock Market News for July 16, 2014 - Market News
Jul 16 / Zacks.com
Why Do We Watch the Dow Jones So Closely When its Makeup Makes No Sense?
Jul 23 / MotleyFool.com
Biotech Stock Roundup: AbbVie Woos Shire with Revised Offer, Sarepta Slips on Eteplir...
Jul 16 / Zacks.com
Gilead Sovaldi $3.5 Billion: The Most Important Number in Biotech Earnings Season
Jul 23 / TheStreet.com
2 Reasons to Watch Bristol-Myers Squibb Co
Jul 15 / MotleyFool.com
Biotech Stock Roundup: AbbVie's Tax Inversion, Amgen Drug Scores in Phase 3 - Analyst...
Jul 23 / Zacks.com
Americans stock up on Tylenol, baby products
Jul 15 / CNNMoney.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.